Board MeetingOutcome of Board Meeting
Alkem Laboratories' board approved strong FY26 consolidated results: Revenue at ₹14,712.27 Cr & Net Profit at ₹2,301.8 Cr.
Alkem Laboratories LimitedALKEM · Filed with the exchange
They also declared a final dividend of ₹10/share (total ₹53/share for FY26) and re-approved Mrs. Madhurima Singh as Executive Director.
No comments yet. Be the first.